Literature DB >> 17264482

Immune privilege and angiogenic privilege of the cornea.

Claus Cursiefen1.   

Abstract

The cornea is the transparent window of the eye and corneal transparency is essential for good vision. Inflammatory reactions within the cornea cannot only cause tissue destruction and scar formation, but are also associated with angiogenesis and lymphangiogenesis in the cornea. Both inflammation-associated processes interfere with corneal transparency and cause corneal blindness. During evolution the cornea has developed mechanisms for preventing and modulating inflammatory and angiogenic reactions. The fact that the cornea is normally devoid of both blood and lymphatic vessels and actively maintains this avascularity has been termed 'corneal angiogenic privilege'. Corneal 'immune privilege', on the other hand, indicates that the cornea is an immune-privileged site and tissue, enabling the extraordinary success of histologically incompatible corneal transplantation. Recent evidence indicates that there is considerable overlap in the molecular mechanisms maintaining corneal 'angiogenic' and 'immune privilege'.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17264482     DOI: 10.1159/000099253

Source DB:  PubMed          Journal:  Chem Immunol Allergy        ISSN: 0079-6034


  62 in total

Review 1.  Wound healing fibroblasts modulate corneal angiogenic privilege: interplay of basic fibroblast growth factor and matrix metalloproteinases in corneal angiogenesis.

Authors:  Jin-Hong Chang; Kyu Yeon Han; Dimitri T Azar
Journal:  Jpn J Ophthalmol       Date:  2010-06-25       Impact factor: 2.447

Review 2.  [Descemet's stripping with automated endothelial keratoplasty (DSAEK)].

Authors:  C Cursiefen; F E Kruse
Journal:  Ophthalmologe       Date:  2008-02       Impact factor: 1.059

Review 3.  [Topical inhibition of angiogenesis at the cornea. Safety and efficacy].

Authors:  B Regenfuss; F Bock; B Bachmann; Y König; D Hos; A Parthasarathy; C Cursiefen
Journal:  Ophthalmologe       Date:  2009-05       Impact factor: 1.059

4.  [Prevention and management of complications in Descemet membrane endothelial keratoplasty (DMEK) and Descemet stripping automated endothelial keratoplasty (DSAEK)].

Authors:  C Cursiefen; P Steven; S Roters; L M Heindl
Journal:  Ophthalmologe       Date:  2013-07       Impact factor: 1.059

Review 5.  Thrombospondin-1 in ocular surface health and disease.

Authors:  William Foulsham; Thomas H Dohlman; Sharad K Mittal; Yukako Taketani; Rohan Bir Singh; Sharmila Masli; Reza Dana
Journal:  Ocul Surf       Date:  2019-06-05       Impact factor: 5.033

Review 6.  Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease.

Authors:  Stefano Barabino; Yihe Chen; Sunil Chauhan; Reza Dana
Journal:  Prog Retin Eye Res       Date:  2012-03-08       Impact factor: 21.198

7.  Identification of prostamides, fatty acyl ethanolamines, and their biosynthetic precursors in rabbit cornea.

Authors:  Paula Urquhart; Jenny Wang; David F Woodward; Anna Nicolaou
Journal:  J Lipid Res       Date:  2015-05-31       Impact factor: 5.922

Review 8.  Wound healing after keratorefractive surgery: review of biological and optical considerations.

Authors:  Dimitri T Azar; Jin-Hong Chang; Kyu Yeon Han
Journal:  Cornea       Date:  2012-11       Impact factor: 2.651

9.  VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis.

Authors:  Todd R Wuest; Daniel J J Carr
Journal:  J Exp Med       Date:  2009-12-21       Impact factor: 14.307

10.  VEGF Trap(R1R2) suppresses experimental corneal angiogenesis.

Authors:  Hailton B Oliveira; Tohru Sakimoto; Joel A D Javier; Dimitri T Azar; Stanley J Wiegand; Sandeep Jain; Jin-Hong Chang
Journal:  Eur J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 2.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.